167 related articles for article (PubMed ID: 10210319)
1. Ex-vivo expansion of bone marrow progenitor cells for hematopoietic reconstitution following high-dose chemotherapy for breast cancer.
Bachier CR; Gokmen E; Teale J; Lanzkron S; Childs C; Franklin W; Shpall E; Douville J; Weber S; Muller T; Armstrong D; LeMaistre CF
Exp Hematol; 1999 Apr; 27(4):615-23. PubMed ID: 10210319
[TBL] [Abstract][Full Text] [Related]
2. Hematopoietic recovery of ex vivo perfusion culture expanded bone marrow and unexpanded peripheral blood progenitors after myeloablative chemotherapy.
Engelhardt M; Douville J; Behringer D; Jähne A; Smith A; Henschler R; Lange W
Bone Marrow Transplant; 2001 Feb; 27(3):249-59. PubMed ID: 11277172
[TBL] [Abstract][Full Text] [Related]
3. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
[TBL] [Abstract][Full Text] [Related]
4. Autologous transplantation of ex vivo expanded bone marrow cells grown from small aliquots after high-dose chemotherapy for breast cancer.
Stiff P; Chen B; Franklin W; Oldenberg D; Hsi E; Bayer R; Shpall E; Douville J; Mandalam R; Malhotra D; Muller T; Armstrong RD; Smith A
Blood; 2000 Mar; 95(6):2169-74. PubMed ID: 10706891
[TBL] [Abstract][Full Text] [Related]
5. Expansion of granulocyte colony-stimulating factor/chemotherapy-mobilized CD34+ hematopoietic progenitors: role of granulocyte-macrophage colony-stimulating factor/erythropoietin hybrid protein (MEN11303) and interleukin-15.
Pierelli L; Scambia G; Bonanno G; Coscarella A; De Santis R; Mele A; Battaglia A; Fattorossi A; Romeo V; Menichella G; Mancuso S; Leone G
Exp Hematol; 1999 Mar; 27(3):416-24. PubMed ID: 10089903
[TBL] [Abstract][Full Text] [Related]
6. Large-scale expansion of human stem and progenitor cells from bone marrow mononuclear cells in continuous perfusion cultures.
Koller MR; Emerson SG; Palsson BO
Blood; 1993 Jul; 82(2):378-84. PubMed ID: 8329697
[TBL] [Abstract][Full Text] [Related]
7. Expansion in bioreactors of human progenitor populations from cord blood and mobilized peripheral blood.
Van Zant G; Rummel SA; Koller MR; Larson DB; Drubachevsky I; Palsson M; Emerson SG
Blood Cells; 1994; 20(2-3):482-90; discussion 491. PubMed ID: 7538353
[TBL] [Abstract][Full Text] [Related]
8. Clinical scale expansion of cryopreserved small volume whole bone marrow aspirates produces sufficient cells for clinical use.
Lundell BI; Mandalam RK; Smith AK
J Hematother; 1999 Apr; 8(2):115-27. PubMed ID: 10349906
[TBL] [Abstract][Full Text] [Related]
9. Increased expansion and differentiation of cord blood products using a two-step expansion culture.
McNiece I; Kubegov D; Kerzic P; Shpall EJ; Gross S
Exp Hematol; 2000 Oct; 28(10):1181-6. PubMed ID: 11027837
[TBL] [Abstract][Full Text] [Related]
10. Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment.
Shpall EJ; Jones RB; Bearman SI; Franklin WA; Archer PG; Curiel T; Bitter M; Claman HN; Stemmer SM; Purdy M
J Clin Oncol; 1994 Jan; 12(1):28-36. PubMed ID: 7505806
[TBL] [Abstract][Full Text] [Related]
11. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells.
Möbest D; Goan SR; Junghahn I; Winkler J; Fichtner I; Hermann M; Becker M; de Lima-Hahn E; Henschler R
Stem Cells; 1999; 17(3):152-61. PubMed ID: 10342558
[TBL] [Abstract][Full Text] [Related]
12. Engraftment with peripheral blood stem cells using noncontrolled-rate cryopreservation: comparison with autologous bone marrow transplantation.
Rosenfeld CS; Gremba C; Shadduck RK; Zeigler ZR; Nemunaitis J
Exp Hematol; 1994 Mar; 22(3):290-4. PubMed ID: 7509292
[TBL] [Abstract][Full Text] [Related]
13. Analysis for recovery and loss of mononuclear cells and colony-forming units granulocyte-macrophage during ex vivo processing of autologous bone marrow.
Schwella N; Heuft HG; Rick O; Blasczyk R; Wittmann G; Huhn D
Vox Sang; 1996; 70(3):132-8. PubMed ID: 8740003
[TBL] [Abstract][Full Text] [Related]
14. Serum-free ex vivo expansion of CD34(+) hematopoietic progenitor cells.
Möbest D; Mertelsmann R; Henschler R
Biotechnol Bioeng; 1998 Nov; 60(3):341-7. PubMed ID: 10099437
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo evidence for the long-term multilineage (myeloid, B, NK, and T) reconstitution capacity of ex vivo expanded human CD34(+) cord blood cells.
Kobari L; Pflumio F; Giarratana M; Li X; Titeux M; Izac B; Leteurtre F; Coulombel L; Douay L
Exp Hematol; 2000 Dec; 28(12):1470-80. PubMed ID: 11146169
[TBL] [Abstract][Full Text] [Related]
16. Ex vivo expansion of CD34+ umbilical cord blood cells in a defined serum-free medium (QBSF-60) with early effect cytokines.
Qiu L; Meagher R; Welhausen S; Heye M; Brown R; Herzig RH
J Hematother Stem Cell Res; 1999 Dec; 8(6):609-18. PubMed ID: 10645768
[TBL] [Abstract][Full Text] [Related]
17. Long-term hematopoietic culture-initiating cells are more abundant in mobilized peripheral blood grafts than in bone marrow but have a more limited ex vivo expansion potential.
Srour EF; Bregni M; Traycoff CM; Agüero B; Kosak ST; Hoffman R; Siena S; Gianni AM
Blood Cells Mol Dis; 1996; 22(1):68-81. PubMed ID: 8807087
[TBL] [Abstract][Full Text] [Related]
18. Cytokine-dependent ex vivo expansion of early subsets of CD34+ cord blood myeloid progenitors is enhanced by cord blood plasma, but expansion of the more mature subsets of progenitors is favored.
Ruggieri L; Heimfeld S; Broxmeyer HE
Blood Cells; 1994; 20(2-3):436-54. PubMed ID: 7538350
[TBL] [Abstract][Full Text] [Related]
19. Expansion of neutrophil precursors and progenitors in suspension cultures of CD34+ cells enriched from human bone marrow.
Smith SL; Bender JG; Maples PB; Unverzagt K; Schilling M; Lum L; Williams S; Van Epps DE
Exp Hematol; 1993 Jul; 21(7):870-7. PubMed ID: 7686502
[TBL] [Abstract][Full Text] [Related]
20. Hematopoietic recovery following high-dose combined alkylating-agent chemotherapy and autologous bone marrow support in patients in phase-I clinical trials of colony-stimulating factors: G-CSF, GM-CSF, IL-1, IL-2, M-CSF.
Laughlin MJ; Kirkpatrick G; Sabiston N; Peters W; Kurtzberg J
Ann Hematol; 1993 Dec; 67(6):267-76. PubMed ID: 7506580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]